Smar NetworkSmar.inSmargrid.comNewsInsuranceRoomsGamesMeasurementsCooking

Insurance Daily News

Daily news and analysis on insurance industry trends, regulations, and market insights

Facebook Telegram
← Back to Insurance News

Core Specialty Files for NYSE Listing

📅 2026-11-17 | 📰 Insurance Business America
#core specialty #nyse #ipo #specialty insurance #private equity

Core Specialty Insurance Holdings, Inc. has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission, signaling plans to list on the New York Stock Exchange under the ticker symbol “CORE.” The offering is being led by J.P. Morgan, Goldman Sachs, and BMO Capital Markets. Notably, the company is not raising new capital through this filing; it will not sell shares or receive proceeds. Instead, the move is intended to establish a public market for existing stockholders, including the private equity firms and institutional investors who facilitated the company’s 2020 recapitalization, to begin reducing their positions.

The insurer, which describes itself as the fourth-largest pure-play specialty insurer in the U.S. by gross written premium, has experienced significant growth since its formation. Gross written premium rose from $457 million in 2020 to $4.57 billion in 2025. The company currently operates 17 divisions spanning property, specialty casualty, and bond, credit, and guarantee lines. Its underwriting performance has also improved, with a combined ratio of 93.0% for the nine months ended September 30, 2026, compared to 98.2% during the same period in the prior year. For the full year 2025, the company reported net income of $118.9 million.

The filing notes that Core Specialty is working to remediate a previously identified material weakness in internal controls. The company also highlighted its reliance on distribution partners, noting that three wholesale brokers accounted for 39% of gross written premium during the nine months ended September 30. While the company maintains an “A” (Excellent) financial strength rating from AM Best, it acknowledges that the loss of key broker relationships could materially impact results.

This listing arrives as the market evaluates how public investors value specialty insurance entities amid a moderating hard market cycle. Unlike private ownership, a public listing will subject the company’s operational dynamics and broker dependencies to quarterly scrutiny, a transition that market observers will watch closely as the company joins other recent specialty insurer entrants in the public equity space.

Why it matters

The transition to public markets will expose Core Specialty's broker-dependent business model to quarterly investor scrutiny as the specialty insurance market cycle moderates.

FAQ

Is Core Specialty raising capital through this NYSE listing?
No. The company is not selling shares or receiving proceeds; the offering is entirely by existing stockholders looking to create a public market for their shares.

What is the primary purpose of the listing?
The company states the principal purpose is to create a public market for its common stock and facilitate future access to public equity markets.

Who are the major backers of Core Specialty?
As of September 30, Enstar’s holding vehicle, Cavello Bay Reinsurance Limited, held approximately 20% of the company, while SkyKnight Capital and Dragoneer Investment Group combined held 43%.

Source: Insurance Business America. See the original source for full details.